{
    "id": 33478,
    "fullName": "ETV6 - JAK1",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "ETV6-JAK1 results from the fusion of ETV6 and JAK1, and leads to growth factor independence, constitutive kinase activity, and increased Stat5 activation and expression of Stat5 target genes (PMID: 10706877, PMID: 20138049). ETV6-JAK1 has been associated with leukemias (PMID: 10706877, PMID: 10374907).",
            "references": [
                {
                    "id": 18551,
                    "pubMedId": 20138049,
                    "title": "A receptor-independent, cell-based JAK activation assay for screening for JAK3-specific inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/20138049"
                },
                {
                    "id": 18552,
                    "pubMedId": 10374907,
                    "title": "Janus kinases and their role in growth and disease.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10374907"
                },
                {
                    "id": 14355,
                    "pubMedId": 10706877,
                    "title": "Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/10706877"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2120,
        "geneSymbol": "ETV6",
        "terms": [
            "ETV6",
            "TEL",
            "TEL/ABL",
            "THC5"
        ]
    },
    "variant": "ETV6 - JAK1",
    "createDate": "04/01/2020",
    "updateDate": "04/01/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 3716,
                "geneSymbol": "JAK1",
                "terms": [
                    "JAK1",
                    "JAK1A",
                    "JAK1B",
                    "JTK3"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 21284,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Pyridone 6 (CMP6) inhibited proliferation of transformed mouse Ba/F3 cells expressing ETV6-JAK1 in culture (PMID: 23471820).",
            "molecularProfile": {
                "id": 36166,
                "profileName": "ETV6 - JAK1"
            },
            "therapy": {
                "id": 2797,
                "therapyName": "Pyridone 6",
                "synonyms": null
            },
            "indication": {
                "id": 2531,
                "name": "hematologic cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 17688,
                    "pubMedId": 23471820,
                    "title": "TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23471820"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 36166,
            "profileName": "ETV6 - JAK1",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}